Acacia Research Corporation (ACTG) : 3 analysts are covering Acacia Research Corporation (ACTG) and their average rating on the stock is 2.33, which is read as a Buy. 2 equity analysts believe that the stock has a bright future and the price doesnt capture all of its upside, hence they rate the stock as a Strong Buy. A Zacks Investment Research rank of 1, which recommends a Strong Buy affirms that they expect a large upside in the stock from the current levels. However, 1 analysts consider that the stock has more downward risks ahead, hence, they suggest a Strong Sell on the stock.
Acacia Research Corporation (ACTG) : 3 investment research analysts covering Acacia Research Corporation (ACTG) have an average price target of $6.67 for the near short term. The highest target price given by the Brokerage Firm to the stock is $8 and the lowest target is $6 for the short term. Analysts expect the variance to be within $0.76 of the average price.
Also, Barclays maintains its view on Acacia Research Corporation (NASDAQ:ACTG) according to the research report released by the firm to its investors. The shares have now been rated Underweight by the stock experts at the ratings house. Barclays raises the price target from $4 per share to $6 per share on Acacia Research Corporation. The rating by the firm was issued on July 29, 2016.
Acacia Research Corporation (NASDAQ:ACTG): After opening at $6.47, the stock dipped to an intraday low of $6.25 on Thursday. However, the bulls stepped in to buy at lower levels and pushed the stock higher. The stock touched an intraday high of $6.62 and the buying power remained strong till the end. The stock closed at $6.56 for the day, a gain of 8.07% for the day session. The total traded volume was 830,606. The stocks close on the previous trading day was $6.07.
Acacia Research Corporation is a holding company. The Company, through its subsidiaries, engaged in patent investment, prosecution, licensing and enforcement activities. The Companys subsidiaries partner with inventors and patent owners for patented inventions. The Companys subsidiaries generate revenues from the granting of intellectual property rights for the use of patented technologies that its subsidiaries control or own. Its subsidiaries own or control the rights to multiple patent portfolios, which include the United States patents and certain foreign counterparts, covering technologies used in a variety of industries. The Company is engaged in licensing and enforcing patented technologies and has licensed over 1,430 license agreements, across 181 of its patent portfolio licensing and enforcement programs.